Agennix AG | Key People and Executives
Christof Hettich
Chairman-Supervisory Board
James D. Weaver
Member-Supervisory Board
Friedrich von Bohlen und Halbach
Member-Supervisory Board
Frank E. Young
Vice Chairman-Supervisory Board
Alan D. Feinsilver
Member-Supervisory Board
Christof Hettich
Chairman-Supervisory Board
Colin Freund
Chief Business Officer & Senior Vice President
Jill Porter
Senior Vice President-Pharmaceutical Development
James D. Weaver
Member-Supervisory Board
Friedrich von Bohlen und Halbach
Member-Supervisory Board
Frank E. Young
Vice Chairman-Supervisory Board
Alan D. Feinsilver
Member-Supervisory Board
Barbara Müller
Manager-IR & Corporate Communications
Gregory H. Hamm
SVP-Human Resources & Corporate Integration
| Address |
Im Neuenheimer Feld 515
Heidelberg Baden Wuerttemberg 69120
Germany
|
|
Employees
|
- |
| Website |
http://www.agennix.com |
| Updated |
09/14/2018 |
| Agennix AG is a biopharmaceutical company, which engages in the development of protein-based drugs for oncology, asthma and wound healing. Its clinical development programs include oral talactoferrin alfa and RGB-286638. The company was founded on November 5, 2009 and is headquartered in Heidelberg, Germany. |
